未登录

E

Erik Björklund

university hospital uppsala

H指数:12

被引数:590

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIRE

ESC HEART FAILURE

IF3.7

2025-01-200

OA

Risk assessment models and survival in pulmonary arterial hypertension: A SPAHR analysis

肺动脉高压的风险评估模型与生存情况：一项SPAHR分析

The Journal of Heart and Lung Transplantation

IF0

2024-11-120

OAAI

Betablockers and clinical outcome after surgical aortic valve replacement: a report from the SWEDEHEART registry

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

IF3

2024-10-070

OA

The four-item PRECISE-DAPT score identifies coronary artery bypass grafting patients with increased risk for post-discharge major bleeding

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY

IF6.1

2024-08-202

OAAI

Statin treatment after surgical aortic valve replacement for aortic stenosis is associated with better long-term outcome

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

IF3

2024-01-253

OA

Postdischarge major bleeding, myocardial infarction, and mortality risk after coronary artery bypass grafting

出院后大出血、心肌梗死和冠状动脉旁路移植术后死亡风险

IF4.4

2023-12-262

OAAI

Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension

慢性血栓栓塞性肺动脉高压患者的五年风险评估和治疗模式

ESC HEART FAILURE

IF3.7

2022-07-041

OA

Associations between medical therapy after surgical aortic valve replacement for aortic stenosis and long-term mortality: a report from the SWEDEHEART registry

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY

IF6.1

2022-05-1811

OAAI

Beta blockers and long-term outcome after coronary artery bypass grafting: a nationwide observational study

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY

IF6.1

2022-01-3110

OAAI

Comparison of Midterm Outcomes Associated With Aspirin and Ticagrelor vs Aspirin Monotherapy After Coronary Artery Bypass Grafting for Acute Coronary Syndrome

JAMA NETWORK OPEN

IF9.7

2021-08-265

OAAI

Renin-angiotensin system inhibition and outcome after coronary artery bypass grafting: A population-based study from the SWEDEHEART registry

INTERNATIONAL JOURNAL OF CARDIOLOGY

IF3.2

2021-05-015

OAAI

Socioeconomic Factors, Secondary Prevention Medication, and Long-Term Survival After Coronary Artery Bypass Grafting: A Population-Based Cohort Study From the SWEDEHEART Registry

JOURNAL OF THE AMERICAN HEART ASSOCIATION

IF5.3

2020-03-0314

OAAI

Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial

EUROPEAN JOURNAL OF HEART FAILURE

IF10.8

2020-02-2617

OAAI

Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry

EUROPEAN HEART JOURNAL

IF35.6

2019-10-2259

OAAI

Ischaemic brain damage after cardiac arrest and induced hypothermia-a systematic description of selective eosinophilic neuronal death. A neuropathologic study of 23 patients

IF4.6

2014-04-0151

PREAI

Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction

EUROPEAN HEART JOURNAL

IF35.6

2006-04-19120

OAAI

Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale, clinical trial

AMERICAN HEART JOURNAL

IF3.5

2004-10-0148

PREAI